The Medical Advisor

Prostate cancer is one of the most common cancers among men, and many turn to dietary supplements as a complementary approach to conventional treatments. This article explores the top prostate cancer-fighting supplements backed by research, along with their recommended dosages, potential side effects, and interactions. 1. Lycopene Benefits: Powerful antioxidant that may slow prostate cancer progression Found in tomatoes, watermelon, and pink grapefruit Recommended Dosage: 10-30 mg daily Potential Side Effects & Interactions: Safe for most people; high doses may cause stomach discomfort Source: National Cancer Institute (NCI) 2. Curcumin (Turmeric Extract) Benefits: Anti-inflammatory and anticancer properties May inhibit prostate cancer cell growth Recommended Dosage: 500-1,000 mg of curcumin extract daily Potential Side Effects & Interactions: May cause digestive discomfort Enhances blood-thinning medications Source: Cancer Research UK 3. Green T...

Abstract Methylene blue (MB), a phenothiazine-derived compound with a well-established history in medical applications, has recently garnered attention for its potential role in cancer therapy. This review examines the pharmacological properties, mechanisms of action, and emerging evidence supporting MB's anticancer effects. Through its redox-cycling capabilities, MB influences mitochondrial function, induces oxidative stress in malignant cells, and exhibits selective cytotoxicity. We further explore preclinical and clinical studies evaluating MB's efficacy and safety, while also discussing challenges and future research directions. Introduction Cancer remains a leading cause of morbidity and mortality worldwide, necessitating novel therapeutic approaches. Methylene blue, a heterocyclic aromatic dye initially introduced as an antimalarial agent, has demonstrated various pharmacological activities, including antimicrobial, neuroprotective, and antioxidant properties. Recently, M...

The main goal with these article is to provide as much clear information as possible for someone dealing with cancer or mRNA Induced Turbo Cancer. This article deals with the basis and practical approach to using Fenbendazole, Mebendazole and Ivermectin. Fenbendazole Literature and Papers: 2024 Baghli et al -  Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol First-in-the-World Ivermectin, Mebendazole and Fenbendazole Protocol in Cancer has been peer-reviewed and published on Sep.19, 2024. Co-authors include Dr Paul Marik and Dr William Makis. 2024 Apr, Rodrigues et al - Repurposing mebendazole against triple-negative breast cancer CNS metastasis 2024 Feb, Eid et al - Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR-2 Inhibitors and Endowed with Apoptotic Potential 2024 Feb, Park et al - The microtubule cytoskeleton: A validated target for the development of 2-Ary...